Root Privileges

2021

The Wire + The Wire Science

  1. After GM Rice Controversy, CDC Finds Deadly Bug in Spray Bottle Made in India (October 23, 2021)
  2. MoEFCC Makes U-Turn on Enlisting Private Entities to Amend Indian Forest Act (October 21, 2021)
  3. India’s Unfortunate Connections to the 2021 Medicine Nobel Prize (October 4, 2021)
  4. ‘Rare Occurrence’: Cyclone Gulab Weakened Over Mainland, to Reemerge as ‘Shaheen’ (September 30, 2021)
  5. New Report Zeroes in on the Grim Cost of India’s Fondness for Coal Power (September 30, 2021)
  6. The Bhatnagar Prizes Are Courting Irrelevance (September 27, 2021)
  7. The Problem With the Idea To Bring Back Woolly Mammoths (September 18, 2021)
  8. JNU Prof Files Defamation Suit Against Journalists, Seeks Rs 50 Lakh in Damages (September 18, 2021)
  9. ICMR ‘Tailored’ COVID Findings to Meet Modi’s ‘Optimistic’ Narrative: NYT (September 14, 2021)
  10. ‘Unjustified’: Experts Write to PM Modi Against Hydro Projects in Ganga Himalaya (September 10, 2021)
  11. News Reports Say Maharashtra Girl Wins NASA Honour, but Is It Another Hoax? (August 20, 2021)
  12. India Ratifies Kigali Amendment to Montreal Protocol, to Phase Out HFCs (August 19, 2021)
  13. COVID-19: Small, Preliminary Study Doesn’t Find Proof of AYUSH 64’s Efficacy (August 19, 2021)
  14. ISRO’s GSLV F10 Mission Fails After Cryogenic Stage Malfunction (August 12, 2021)
  15. On August 15, Swallow the ‘Modicine’ and Declare our Independence from Science (August 5, 2021)
  16. NCBS Retraction: As TIFR Studies Report, More Researchers Come Under Scanner (July 29, 2021)
  17. NCBS Retraction: New Allegations Intensify Spotlight on Institute (July 14, 2021)
  18. NCBS: When a Paper Is Published but One Author Is Found Guilty of Misconduct… (July 7, 2021)
  19. Bharat Biotech’s Covaxin Paper Ignores People’s Hospital Fiasco, Impact on Trial Unclear (July 5, 2021)
  20. Bharat Biotech Releases Long-Awaited Covaxin Phase 3 Data, Claims 77.8% Efficacy (July 3, 2021)
  21. Experts Write to Prez To Withdraw ‘Incautious’ Draft Lakshadweep Regulation 2021 (June 24, 2021)
  22. Is the Google Maps Island off Kochi Really an Island? (June 18, 2021)
  23. Appointed Experts Say They Didn’t Ask to Double Covishield Dose Gap, Govt Denies (June 16, 2021)
  24. When Legit Research is Presented as ‘Controversial’, Good Luck Getting Science’s Help (June 13, 2021)
  25. US FDA Denies Bharat Biotech’s Covaxin Emergency Use Approval (June 11, 2021)
  26. Only 56% Of Healthcare, 47% Of Frontline Workers Fully Vaccinated: Health Min (June 11, 2021)
  27. Governor Opens New ‘Cow Research’ Unit in Gujarat Technological University (June 7, 2021)
  28. Study Finds Both Covaxin, Covishield Good – but Issues Mar Other Results (June 7, 2021)
  29. Speculation Over COVID-19 Origins Fuels US-China Tension (May 30, 2021)
  30. Delhi Govt Regulations Suggest Gag on Info About Managing Black Fungus (May 28, 2021)
  31. Ahead of Cyclone Yaas, Tornado Strikes West Bengal’s South (May 26, 2021)
  32. COVID Vaccines: Without WHO Approval, Covaxin Remains Second Among Equals (May 25, 2021)
  33. IT Ministry Warns Social Media Platforms Against Use of ‘Indian Variant’ for B.1.617 (May 23, 2021)
  34. For Strong Protection Against B.1.617.2 COVID, Need Two Covishield Doses: Study (May 23, 2021)
  35. What PSA’s New COVID Advisory Doesn’t Say Is as Important As What It Does (May 20, 2021)
  36. After India, B.1.617 Variant Found in 44 Countries, Spurs Fear of Global Surge (May 19, 2021)
  37. ICMR Removes ‘Plasma Therapy’ From COVID-19 Management Protocols (May 18, 2021)
  38. Virologist Shahid Jameel Quits India’s Genome Sequencing Consortium (May 17, 2021)
  39. Covaxin and Covishield Invoked Fewer Antibodies Against B.1.617 Variant: Report (May 15, 2021)
  40. TN Revises Protocols, Leaves Out Ivermectin for COVID Patients (May 15, 2021)
  41. Centre Widens Covishield Dose Gap to 12-16 Weeks, Buys Time To Fix Shortage (May 13, 2021)
  42. In COVID Origins Storm, Fauci Denies US Funded Controversial Study in Wuhan (May 12, 2021)
  43. COVID: Public Health Experts Pen Concerns About Plasma to PSA VijayRaghavan (May 11, 2021)
  44. COVID: SC Sets up National Task Force To Help Centre With ‘Scientific’ Solutions (May 8, 2021)
  45. Studies Say Pfizer Vaccine Very Effective Against B.1.1.7, B.1.351 Variants (May 6, 2021)
  46. After Centre Ignored INSACOG Warning, Surge Undoes ‘Supermodel’ Predictions (May 5, 2021)
  47. Making Sense of the Spat Between Anvisa and Gamaleya Over Sputnik V Vaccines (May 4, 2021)
  48. 25 Alumni of IIT Bombay Write to IIT Kharagpur Director Over Seema Singh’s Remarks (April 29, 2021)
  49. COVID-19: With Over 3.7 Lakh New Cases, Another Record Single-Day Spike (April 29, 2021)
  50. Vardhan and SII Statements Keep Covishield Price Confusion Alive (April 26, 2021)
  51. India Reports 3.45 Lakh New Cases, US Refuses To Allow Vaccine Ingredients Export (April 24, 2021)
  52. India Reports 3.32 Lakh New Cases, China Offers Helping Hand (April 23, 2021)
  53. India Reports World’s Highest Number of New COVID-19 Cases in 24 Hours (April 22, 2021)
  54. India Reports Over 2,000 COVID Deaths in Single Day, CEA Predicts Mid-May Peak (April 21, 2021)
  55. Cyclone Wrecks Australia West Coast, Super-Typhoon Slams Into Philippines (April 20, 2021)
  56. As India Reports 2.56 Lakh Cases, Modi Announces Confusing Vaccine Update (April 20, 2021)
  57. COVID-19: Oxygen To Be Transported by Trains, Supply Diverted From Industries (April 19, 2021)
  58. India Reports 2.7 Lakh New COVID Cases, Cumulative Cases Crosses 1.5 Crore (April 19, 2021)
  59. COVID-19: As Thousands Gasp for Oxygen, Government Tardiness in Spotlight (April 19, 2021)
  60. India Going Through a Spate of U-Turns in Scramble To Stem COVID-19 Tide (April 17, 2021)
  61. India’s COVID-19 Story Goes From Bad To Worse With 2.17 Lakh New Cases (April 16, 2021)
  62. India Reports 2 Lakh New COVID-19 Cases on Single Day, Spike in Haridwar (April 15, 2021)
  63. COVID-19: Queues at Crematoria Again Suggest Inconsistencies in Official Data (April 14, 2021)
  64. US Recommends Pausing Johnson & Johnson Vaccine After Blood Clot Reports (April 13, 2021)
  65. India Reports 1.7 Lakh New Cases, Five States Report 10k Cases Each (April 12, 2021)
  66. COVID-19: Gujarat BJP Chief Gives Remdesivir for Free, Sans Proper Safeguards (April 12, 2021)
  67. India Sees 1.45 Lakh New COVID-19 Cases, More Than 10 Lakh Cases Active (April 10, 2021)
  68. COVID-19: In PM Modi’s CMs Meet, Vaccine Shortage Takes Centre Stage (April 9, 2021)
  69. 617 Serious Adverse Events After Vaccination Reported In India Until March 29 (April 9, 2021)
  70. Muon g-2 Anomaly: US Experiments Find Hint of a Crack in the Laws of Physics (April 8, 2021)
  71. 100,000 New COVID-19 Cases, Bad Governance Hold India at Brink of Disaster (April 5, 2021)
  72. Top US Body Recommends Funding for Controversial Solar Geoengineering Research (March 30, 2021)
  73. Mumbai Seeks Permission for Door-To-Door Vaccination Plan, Centre Says No (March 30, 2021)
  74. A Year After First Lockdown, Mumbai in the Throes of COVID-19 Again (March 26, 2021)
  75. India Sees Over One Lakh New COVID-19 Cases in Two Days, Highest in 2021 (March 25, 2021)
  76. Supply Issues Dog Covaxin, Covishield as India Ups COVID-19 Vaccination Pace (March 24, 2021)
  77. COVID-19 Vaccine Available for Everyone Above 45 From April 1: Health Ministry (March 23, 2021)
  78. AstraZeneca Clears Europe Blood Clot Hurdle but Indian Regulators Insist on Secrecy (March 20, 2021)
  79. Experts Press Officials in Charge of Vaccine Drive for Info on Adverse Events (March 18, 2021)
  80. India Has Exported 5.84 Crore Doses of COVID-19 Vaccines To 70 Countries: Data (March 17, 2021)
  81. France, Germany Pause AstraZeneca Rollouts Over Sporadic Blood Clot Reports (March 16, 2021)
  82. India Reports Biggest Weekly Jump in COVID-19 Cases Since July 2020 (March 15, 2021)
  83. India Expected To Review Covishield After Reports of Blood Clots After Vaccination (March 14, 2021)
  84. Antarctic Telescope Finds Sign of Strange Phenomenon Predicted 60 Years Ago (March 11, 2021)
  85. India Retains Short Dose Gap For Covishield Despite Data To The Contrary (March 10, 2021)
  86. Led by Maharashtra, India’s COVID-19 Case Load Is Rising Again (March 8, 2021)
  87. Interim Results Show Covaxin Is 81% Effective, Bharat Biotech Says (March 3, 2021)
  88. As Coronavirus Vaccine Drive Expands, Co-WIN Glitches Cause Some Delays (March 3, 2021)
  89. Modi Only World Leader to Use Vaccination Certificate to Push Cult of Personality (March 1, 2021)
  90. India Kicks off Phase 2 of Vaccination Drive, Co-WIN Opens for Public Registration (March 1, 2021)
  91. Sci-Hub Case: Academics Urge Court To Rule Against ‘Extortionate Practices’ (February 25, 2021)
  92. Breakthrough Science Society Condemns UGC’s Promotion of ‘Cow Science’ Exam (February 23, 2021)
  93. Why Does the Idea That SARS-CoV-2 Came From a Lab Persist? (February 15, 2021)
  94. Chhattisgarh Health Min Refuses Covaxin Over Efficacy Doubts, Vardhan Replies (February 12, 2021)
  95. Govt Refutes Causal Link Between Candidate Vaccine Shots, Health Worker Deaths (February 8, 2021)
  96. DNA Bill: Standing Committee Makes Slew of Recommendations To Govt (February 4, 2021)
  97. Expenses of Science, Health, Environment Departments of Interest, 2014-2019 (February 1, 2021)
  98. Covaxin Trial’s Info Sheet Skips Mention of Two Rare but Known Risks (January 29, 2021)
  99. Economic Survey Takes Aim at Out-of-Pocket Spend, High Private Healthcare Costs (January 29, 2021)
  100. The Sensible, the Debatable and the Bizarre in CEA’s Defence of India’s Lockdown (January 29, 2021)
  101. EU May Block AstraZeneca Vaccine for 65+ Group After Controversy in Germany (January 29, 2021)
  102. Home Secy Ajay Bhalla Asks States To Prosecute People for Vaccine Safety ‘Rumours’ (January 25, 2021)
  103. Pune: Five People Die in Massive Fire at Serum Institute of India Building (January 22, 2021)
  104. Hesitancy + App Glitches = ‘Sluggish’ Response to India’s Vaccination Drive (January 18, 2021)
  105. Allergy-Like Reactions To COVID-19 Vaccine Candidates an ‘Expected Effect’ (January 17, 2021)
  106. COVID-19 Vaccine Roll-Out FAQ: Dos, Don’ts and Other Tips (January 16, 2021)
  107. Dear Health Ministry – Do You Know What Good Science Is? (January 15, 2021)
  108. What Does Treating Covaxin and Covishield ‘Equally’ Entail? (January 15, 2021)
  109. Despite Mounting Disputes, Govt Presses Ahead With Vaccine Roll Out (January 12, 2021)
  110. Serum Institute Vaccine To Be Rs 200 per Dose, PM CARES Will Bear Cost (January 11, 2021)
  111. India’s Vaccine Approvals Had One Problem. It Gave Rise To the Other Two. (January 5, 2021)
  112. DCGI’s Covaxin Verdict Forces First Vaccine Recipients To Make a Tough Call (January 4, 2021)
  113. COVID-19 Vaccines: What We Lose When We Lose Public Accountability (January 4, 2021)
  114. ‘Never Seen Anything Like it’: Gagandeep Kang on India’s Vaccine Approvals (January 4, 2021)
  115. 10 Questions the DCGI Needs To Answer About the Two Vaccine Candidates Approved (January 3, 2021)
  116. DCGI Okays Bharat Biotech, Serum Institute Candidates for Restricted Emergency Use (January 3, 2021)
  117. All You Need to Know About Bharat Biotech and Covaxin During the Pandemic (January 3, 2021)
  118. India Approves Two Vaccine Candidates, But Let’s Not Pretend Everything Is Okay (January 2, 2021)